These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 11570032

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use.
    al-Assi MT, Genta RM, Karttunen TJ, Graham DY.
    Endoscopy; 1996 Feb; 28(2):229-33. PubMed ID: 8739738
    [Abstract] [Full Text] [Related]

  • 3. [Gastroduodenal lesions and non-steroidal anti-inflammatory agents. What role does Helicobacter pylori play in this relationship?].
    Gisbert JP, Boixeda D, Martín de Argila C, García Plaza A.
    Rev Esp Enferm Dig; 1998 Sep; 90(9):655-64. PubMed ID: 9780802
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Endoscopic characteristics and Helicobacter pylori infection in NSAID-associated gastric ulcer.
    Kamada T, Hata J, Kusunoki H, Sugiu K, Tanimoto T, Mihara M, Hamada H, Kido S, Dongmei Q, Haruma K.
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):98-102. PubMed ID: 16706819
    [Abstract] [Full Text] [Related]

  • 6. Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?
    Chan FK.
    Chin J Dig Dis; 2005 Jan; 6(1):1-5. PubMed ID: 15667550
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Helicobacter pylori, nonsteroidal anti-inflammatory agents and gastroduodenal changes].
    Teixeira AV.
    Acta Med Port; 1995 Sep; 8(9):517-21. PubMed ID: 7484272
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S, Ittel TH, Wietholtz H.
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. NSAID--induced gastroduodenal ulcers: exploring the silent dilemma.
    Mohamed AH, Salena BJ, Hunt RH.
    J Gastroenterol; 1994 Jul; 29 Suppl 7():34-8. PubMed ID: 7921152
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [What role today for Helicobacter pylori in peptic ulcer?].
    Cadiot G.
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):409-14. PubMed ID: 12700497
    [Abstract] [Full Text] [Related]

  • 17. Nonsteroidal antiinflammatory drug-induced mucosal lesions of the upper gastrointestinal tract and their relationship to Helicobacter pylori.
    Rybár I, Masaryk P, Mateicka F, Kopecký S, Rovenský J.
    Int J Clin Pharmacol Res; 2001 Mar; 21(3-4):119-25. PubMed ID: 12067141
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
    Arroyo MT, Forne M, de Argila CM, Feu F, Arenas J, de la Vega J, Garrigues V, Mora F, Castro M, Bujanda L, Cosme A, Castiella A, Gisbert JP, Hervas A, Lanas A.
    Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.